Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care

BACKGROUND: To characterize the use of nephrotoxic medications in patients with chronic kidney disease (CKD) Stages G3–5 in routine care. METHODS: We studied cohorts of adults with confirmed CKD G3–5 undergoing routine care from 1 January 2016 through 31 December 2018 in two health systems [Stockhol...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosi, Alessandro, Xu, Yunwen, Gasparini, Alessandro, Wettermark, Björn, Barany, Peter, Bellocco, Rino, Inker, Lesley A, Chang, Alex R, McAdams-DeMarco, Mara, Grams, Morgan E, Shin, Jung-Im, Carrero, Juan J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922703/
https://www.ncbi.nlm.nih.gov/pubmed/35296039
http://dx.doi.org/10.1093/ckj/sfab210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922703/
https://www.ncbi.nlm.nih.gov/pubmed/35296039
http://dx.doi.org/10.1093/ckj/sfab210

Ejemplares similares